Nickl Therapeutics Email Formats

Biotechnology Research • • 1-10 Employees

Key Contact at Nickl Therapeutics

Victoria Arena

Scientific Co-founder

Company overview

Headquarters	XX
NAICS	541714
Founded	2023
Employees	1-10

About Nickl Therapeutics

Developing next-generation NK cell and innate lymphoid cell therapeutics for oncology and auto-immune disease. By utilizing highly innovative macrocyclic multi-specific cell engagers, Nickl aims to redirect the cytotoxic capabilities of NK cells for the precision killing of disease mediating cells across a number of therapeutic settings. Initial focus is on the activation of the innate immune system within the microenvironment of solid tumors to enhance cancer cell killing and provide improved patient outcomes in indications with significant unmet need.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Nickl Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Nickl Therapeutics has never raised funding before.

Frequently asked questions

Nickl Therapeutics is located in XX.

Nickl Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Nickl Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Nickl Therapeutics

Victoria Arena

Scientific Co-founder

4.8

40,000 users